Literature DB >> 28687692

Diencephalic syndrome: a rare cause of failure to thrive.

Mustafa Tosur1, Anca Tomsa1, David L Paul1.   

Abstract

Timely diagnosis of diencephalic syndrome is not often the case for patients presenting with failure to thrive (FTT) because of its rarity and lack of specific symptoms. Herein, we report two cases of diencephalic syndrome (2-year-old girl and 10-month-old boy) presenting with severe emaciation. Both patients had histories of poor weight gain for months despite having good appetites prior to diagnosis. Initial work-up did not reveal the diagnosis. Horizontal nystagmus was noted in both patients: by a neurologist in the first patient and by a family member in the second patient. MRI of the brain showed large suprasellar mass and pilocytic astrocytoma was confirmed by pathology in each case. The patients were started on appropriate chemotherapy with interval improvements in weight gain. These cases illustrate the importance of cranial imaging and consideration of diencephalic syndrome for children presenting with FTT despite normal or increased caloric intake. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  failure to thrive; infant health

Mesh:

Year:  2017        PMID: 28687692      PMCID: PMC5534923          DOI: 10.1136/bcr-2017-220171

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Diencephalic syndrome due to hypothalamic tumor: a model of the relationship between weight and puberty onset.

Authors:  Raja Brauner; Christine Trivin; Michel Zerah; Jean-Claude Souberbielle; François Doz; Chantal Kalifa; Christian Sainte-Rose
Journal:  J Clin Endocrinol Metab       Date:  2006-04-18       Impact factor: 5.958

2.  Diencephalic syndrome: clinical features and imaging findings.

Authors:  T Y Poussaint; P D Barnes; K Nichols; D C Anthony; L Cohen; N J Tarbell; L Goumnerova
Journal:  AJNR Am J Neuroradiol       Date:  1997-09       Impact factor: 3.825

Review 3.  Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance.

Authors:  Amy Fleischman; Catherine Brue; Tina Young Poussaint; Mark Kieran; Scott L Pomeroy; Liliana Goumnerova; R Michael Scott; Laurie E Cohen
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

4.  The role of leptin in diencephalic syndrome.

Authors:  Pablo Velasco; María Clemente; Raquel Lorite; M Clara Ventura; Luis Gros; José Sanchez de Toledo; Soledad Gallego
Journal:  Pediatrics       Date:  2013-12-23       Impact factor: 7.124

5.  Inappropriate growth hormone release in the diencephalic syndrome of childhood: case report and 4 year endocrinological follow-up.

Authors:  S L Drop; H J Guyda; E Colle
Journal:  Clin Endocrinol (Oxf)       Date:  1980-08       Impact factor: 3.478

6.  Increased energy expenditure in a patient with diencephalic syndrome.

Authors:  E Vlachopapadopoulou; K J Tracey; M Capella; C Gilker; D E Matthews
Journal:  J Pediatr       Date:  1993-06       Impact factor: 4.406

7.  Diencephalic syndrome: a frequently neglected cause of failure to thrive in infants.

Authors:  Ahlee Kim; Jin Soo Moon; Hye Ran Yang; Ju Young Chang; Jae Sung Ko; Jeong Kee Seo
Journal:  Korean J Pediatr       Date:  2015-01-31
  7 in total
  2 in total

1.  Transition From Diencephalic Syndrome to Hypothalamic Obesity in Children With Suprasellar Low Grade Glioma: A Case Series.

Authors:  Ichelle M A A van Roessel; Antoinette Y N Schouten-van Meeteren; Lisethe Meijer; Eelco W Hoving; Boudewijn Bakker; Hanneke M van Santen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-06       Impact factor: 6.055

Review 2.  Diencephalic syndrome in childhood, a challenging cause of failure to thrive: miniseries and literature review.

Authors:  Sandra Trapani; Barbara Bortone; Martina Bianconi; Chiara Rubino; Iacopo Sardi; Paolo Lionetti; Giuseppe Indolfi
Journal:  Ital J Pediatr       Date:  2022-08-17       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.